← All Fortress Biotech, INC filings

Fortress Biotech, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
FBIO
Fortress Biotech, INC
DEFA14A: Fortress Biotech 2025 Annual Meeting: Stockholders to Vote on Key Proposals
Fortress Biotech's upcoming annual meeting will address director elections, auditor ratification, executive compensation, and a certificate of incorporation amendment.
NASDAQ
FBIO
Fortress Biotech, INC
DEF: Fortress Biotech Seeks Stockholder Approval for Officer Exculpation and Director Elections at 2025 Annual Meeting
Fortress Biotech is holding its annual stockholder meeting on June 17, 2025, to elect directors, ratify the accounting firm, approve executive compensation, and amend the corporate charter to include officer exculpation.
NASDAQ
FBIO
Fortress Biotech, INC
DEFA14A: Fortress Biotech to Hold Virtual Annual Meeting on May 23, 2024; Proposes Stock Incentive Plan Amendment
Fortress Biotech, Inc. will hold its annual stockholder meeting virtually on May 23, 2024, to vote on director elections, ratification of KPMG LLP, and amendments to stock incentive plans.
NASDAQ
FBIO
Fortress Biotech, INC
DEF 14A: Fortress Biotech Seeks Stockholder Approval for Director Elections, Auditor Ratification, and Incentive Plan Amendments
Fortress Biotech is holding its annual stockholder meeting to elect directors, ratify auditors, and approve amendments to its stock incentive and purchase plans.